SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-17-028422
Filing Date
2017-12-11
Accepted
2017-12-11 15:24:49
Documents
1
Period of Report
2017-12-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 14671
  Complete submission text file 0000899243-17-028422.txt   16168
Mailing Address 555 TWIN DOLPHIN DRIVE SUITE 615 REDWOOD CITY CA 94065
Business Address 555 TWIN DOLPHIN DRIVE SUITE 615 REDWOOD CITY CA 94065 6504750158
Ocera Therapeutics, Inc. (Issuer) CIK: 0001274644 (see all company filings)

IRS No.: 631192270 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O OCERA THERAPEUTICS 525 UNIVERSITY AVENUE, SUITE 610 PALO ALTO CA 94301
Business Address
Bukofzer Stan (Reporting) CIK: 0001663041 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35119 | Film No.: 171249407